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Echocardiography remains the modality of choice for diagnosis and follow-up in heart disease as it is 
relatively risk-free, mobile (even portable) and – importantly – cheap and therefore widely available. 
Although improvements in ultrasound technology have resulted in more accurate, reproducible, 
faster and user-friendly methodologies towards the morphologic and functional evaluation of the 
heart, to date, no robust ultrasound methodology is available for clinical routine to determine tissue 
viability. As tissue viability is an important boundary condition for treatment options and treatment 
outcome, patients are often referred – for this reason – to other imaging modalities such as MRI or 
PET. Viability imaging could therefore be considered the Achilles tendon of echocardiography. 
Not surprisingly, it has thus been an active research topic for decades and new approaches to assess 
viability were proposed hand-in-hand with evolutions in ultrasound imaging technology. Although it 
was demonstrated that irreversibly damaged, i.e. non-viable, myocardium is thicker than 
dysfunctional but viable, i.e. stunned, myocardium early after reperfusion of acute myocardial 
infarctions [1], most methodologies did not directly measure tissue properties but rather focused on 
assessing the variable functional reserve of stunned versus infarcted myocardium. For example, 
stress echocardiography has demonstrated that stunned segments show preserved contractile 
reserve while infarcted segments do not [2]. Similarly, Doppler myocardial imaging [3] and speckle 
tracking echocardiography [4] during stress echocardiography provide a similar differentiation but in 
a more quantitative manner. In the eighties, it was demonstrated that the cyclic variation of the 
integrated backscatter could equally differentiate stunned from infarcted myocardium [5]. Finally, 
the assessment of myocardial perfusion using ultrasound contrast echocardiography has shown to 
differentiate both ischemic substrates [6]. 
Without doubt, the major technological evolution of ultrasound imaging in the last decade has been 
fast imaging and likely this will be similar in the decade to come. Although the frame rate of 
echocardiography has always been adequate to look at the gross motion of the heart, it is not until 
recently that imaging strategies were proposed that allow imaging the heart at very high temporal 
resolution with frame rates going up to 10.000Hz. Although it may seem unnecessary to image the 
heart at this time scale, it does allow extracting new information that could be of (added) diagnostic 
value [7]. 
In this issue of JACC Cardiovascular Imaging, Pernot and colleagues report on an experimental animal 
study demonstrating the potential use of one of these new parameters in differentiating infarcted 
from stunned myocardium. More specifically, the authors used ultrafast imaging to measure the 
propagation speed of shear waves, acoustically induced in the myocardium, thereby estimating local 
myocardial stiffness. Interestingly, this methodology characterizes the native tissue (mechanical) 
properties rather than the functional consequences of viability. The authors convincingly 
demonstrated that stunned myocardium returns to near normal elastic properties within minutes 
after reperfusion while infarcted myocardium continues to stiffen after reperfusion. Importantly, 
these findings were not only obtained with the novel ultrafast imaging approach but validated by an 
independent, invasive estimate of local stiffness. 
The findings of Pernot et al. are perfectly in line with those of Pislaru et al. [Pislaru04]. Indeed, on the 
one hand, Pislaru and colleagues measured the response of ventricular wall thickness on changing 
left ventricular pressure as a result of vena cava occlusion; on the other hand, they measured the 
local tissue deformation (i.e. strain) as a result of left ventricular pressure increase during atrial 
contraction. Both approaches allowed estimating local tissue stiffness and demonstrated that non-
viable myocardium is stiffer than viable myocardium early after reperfusion. 
An important improvement of the ultrafast imaging methodology proposed by Pernot et al. is that it 
provides absolute stiffness measures. Indeed, although strain induced by atrial contraction was 
different for stunned and infarcted myocardium in an experimental animal setting [Pislaru04], 
translating their methodology to clinical practice is difficult as many confounding factors can result in 
equally low local strain values during atrial contraction: global LV dilation; local LV shape and wall 
thickness changes that are in turn related to infarct size, location and transmurality; changed LV 
compliance; poor left atrial function; and others. Moreover, assessing myocardial stiffness in 
absolute value (i.e. in kPa)  - as done by Pernot et al. – not only implies that these confounding 
factors can be mostly neutralized but also that local myocardial stiffness can be compared between 
individuals. As such, it becomes possible to define clear threshold values to differentiate viable from 
non-viable myocardium without the need to correct for confounders. In this context, it appears very 
promising that the stiffness of non-viable myocardium was an order of magnitude different from that 
of normal / viable myocardium (12.1 versus 2.3kPa respectively) and that the range of normal values 
was very narrow (standard deviation 0.4kPa). 
Does this methodology then finally solve the weak spot of echocardiography? Did we finally get a 
robust and reliable ultrasound methodology to predict functional recovery of segments after 
reperfusion of an acute myocardial infarction as a first application of viability imaging? 
Unfortunately, the answer to these questions remains negative for clinical as well as technological 
reasons. Indeed, in clinical practice, the range of ischemic substrates encountered is more diverse 
than the two extreme situations created in this animal study, i.e. stunned versus transmural 
infarction. In particular, non-transmural infarctions will equally often be encountered, resulting in a 
more heterogeneous substrate that might lead to intermediate stiffness values when measured at 
the segmental level thereby complicating the viability classification. Of course, one could hope that 
the spatial resolution of the ultrafast imaging approach is sufficiently high in order to make a stiffness 
estimate at different depths across the wall leading to a stiffness image that might be read very 
similar to an MRI delayed enhancement image. This might be the case as the team of Pernot 
previously demonstrated that the shear wave speed can be measured at different depths across the 
myocardial wall in order to determine local fibre orientation based on the fact that these shear 
waves travel faster along the fibre than across them [8]. Unfortunately, this implies that a change in 
shear wave speed across the wall cannot simply be related to local stiffness as local fiber orientation 
should be considered. Although this confounder may be corrected for, it does complicate 
classification. 
A more fundamental problem of the proposed methodology might be the technological challenges 
related to its translation to the clinical setting. Indeed, inducing shear waves in the anterior wall of an 
open-chest animal preparation and imaging their propagation at ultra-high frame rate by a linear 
array transducer in direct contact with the heart is quite distinct from inducing a shear wave in any 
other wall of a closed-chest patient and imaging its propagation through a narrow acoustic window 
for the following reasons: i) the induction of shear waves requires insonification of the tissue with 
sufficient acoustic energy in order to be able to push the tissue away from the transducer via its 
acoustic radiation force – this is not obvious further away from the transducer due to attenuation 
particularly when using a transducer with a small footprint (i.e. a transthoracic phased array) that 
limits focusing; ii) for the shear wave to be generated and detected using the same (2D) transducer 
position as required by the presented methodology, the only echocardiographic view that can be 
used is the parasternal one – this implies that stiffness can only be measured in the anterior and 
posterior wall segments; iii) ultrafast imaging is facilitated by linear arrays with large footprint and 
therefore an intrinsic large field of view – translation to phased arrays is not straightforward 
although solutions are being proposed. 
Despite the challenges in translating the proposed methodology to the clinical setting, this study 
convincingly demonstrates the potential of stiffness imaging of the heart. Although it may not allow 
mapping local stiffness (changes) bedside in its present implementation, new technological advances 
may solve this. Moreover, even if local stiffness maps remain unfeasible, the technique presented 
may still be of great value for example to determine the aetiology of diastolic heart failure by 
obtaining a quantitative estimate of (local) ventricular compliance. It is thus clear that this study is 
just the tip of the iceberg and that many exciting applications of ultrafast cardiac imaging are yet to 
come. Without doubt, ultrafast cardiac imaging will further strengthen ultrasound as the cardiac 
imaging modality and it is again Paris that finds the weak spot of Achilles; this time not to murder 
him but rather to help making him truly invincible. 
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